Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | -2.06% | +16.92% | +29.25% |
05-07 | Cogent Biosciences Q1 Loss Widens | MT |
05-07 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.25% | 742M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Baird Downgrades Cogent Biosciences to Neutral From Outperform, Adjusts Price Target to $8 From $14